The clinical study on prophylactic radiation therapy on sacral lymph nodes after radical resection of cervical cancer
10.3781/j.issn.1000-7431.2010.01.012
- VernacularTitle:宫颈癌根治术后骶前淋巴结区域是否需要预防性治疗的临床研究
- Author:
Yaqin QU
;
Yubao HE
;
Xin JIANG
;
Xiaojing JIA
;
Yanming YANG
;
Shaohua WANG
- Publication Type:Journal Article
- Keywords:
Uterine cervical neoplasms;
Radiotherapy,conformal;
Lymph nodes;
Radiation proctitis
- From:
Tumor
2010;(1):57-61
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study whether sacral lymph nodes should be included in the target volume delineation for those patients with early (stageⅠB-ⅡA) uterus cervix cancer during postoperative radiotherapy. Methods:Forty-six patients with early uterus cervix cancer were given postoperative three dimensional conformal radiation therapy (3D-CRT) in our department for one month after radical resection. The patients were randomly divided into two groups. The sacral lymph nodes were not included in the target volume delineation in the treatment group. But they were delineated in control group. All the patents had no radiotherapy-related contraindications and signed the consent agreement. The patients were followed up. The local controlling rate and the incidence and degree of radioactive proctitis were compared between the two groups. Results:The local controlling rate of the two groups had no significant difference(t=0.000, P=1.000). The doses received by the 5% and 95% volume of the rectum(V_5, V_95), the average dose, and the minimum dose had significant difference between the two groups(t_(V5)=2.169, P_(V5)=0.041; t_(V95)=4.036, P_(V95)=0.001;t_(mean)=2.236, P_(mean)=0.036; t_(min)=2.265, P_(min=0.034), but the maximum dose received by the rectum had no obvious difference (t_(max)=0.518, P_(max)=0.610). The incidence of radioactive proctitis had significant difference between the two groups(t=2.174, P=0.190). Conclusion:For the early uterus cervix cancer patients who have recurrent risk after radical surgery, sacral lymph nodes should not be included in the delineation of target volume during 3D-CRT in order to decrease the incidence of radioactive proctitis.
